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Heavy alcohol use in young adults has been prospectively associated with a host of psy-
chosocial and alcohol-related problems. Recent studies have supported the interaction
between serotonin transporter polymorphism and adverse environmental factors, as a
predictor of alcohol use and the development of alcohol dependence. The current study
examined the role of depressive symptoms in combination with the serotonin transporter
polymorphism as a predictor of alcohol use and alcohol-related problems. Results revealed
a signiﬁcant genotype by depressive symptom interaction, such that heavier alcohol use
was associated with depressive symptoms in L allele homozygotes but not among S allele
carriers.These results remained signiﬁcant after controlling for ethnicity and gender effects.
These ﬁndings extend the emerging literature supporting 5-HTTLPR genotype as a risk
factor for alcohol-related problems in the context of co-occurring symptoms of depression.
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INTRODUCTION
Alcohol use disorders (AUDs) affect approximately 8.5% of the
U.S. adult population (Grant et al., 2004) and account for $185
billion in costs related to the psychiatric andmedical consequences
of heavy drinking (Harwood, 2000). Given that the onset of alco-
holism occurs largely before age 30, recent studies have focused
on genetic and environmental factors that affect young people
(Hingson and Zha, 2009).
Alcohol use in young adults is especially problematic as early
age of ﬁrst use is associatedwith a later increase in psychosocial and
alcohol-related problems (Tapert et al., 1999; Rowe et al., 2004).
Both genetic and environmental factors contribute to the onset
of problem drinking in adolescence and early adulthood. Genetic
factors account for an estimated 40–60% of the risk of developing
AUDs (Kendler et al., 1994; Prescott et al., 1999; Schuckit, 2009).
At the neurobiological level, the serotonin neurotransmitter sys-
tem appears to be important to alcohol phenotypes via its relation
to impulsivity, negative mood, craving, and response to alcohol
(Heinz et al., 2004; Hinckers et al., 2006).
A polymorphism which has been directly associated with alco-
hol dependence in the 5′ promoter region (5-HTTLPR) of the
serotonin transporter gene (locus ID SLC6A4) is of particular
interest to neuropsychiatric genetics, including genetics of alco-
holism. This 44-bp deletion/insertion polymorphism results in
two common alleles, the 528-bp long allele (L) and the 448-bp
short allele (S). The S allele has been shown to decrease transcrip-
tion and decrease 5-HT reuptake in vitro (Heils et al., 1997) and
in vivo (Heinz et al., 2000). The L allele has been associated with a
predisposition to lowered level of response to alcohol, which is in
turn associated with the onset of AUDs (Bleich et al., 2007). Addi-
tionally, the L allele has been associated with early onset of AUDs,
earlier age of ﬁrst drink (Buchmann et al., 2009), higher rates of
AUD, a heavier drinking pattern, and higher alcohol craving (Hu
et al., 2005; Olsson et al., 2005; Hinckers et al., 2006; Bleich et al.,
2007).
In contrast to studies reporting an association between the L
allele and alcohol problems, there is recent evidence suggesting
that the S allele has a small, but direct relationship to the develop-
ment of AUDs (Feinn et al., 2005; McHugh et al., 2010). Studies
examining gene× environment interactions have producedmixed
evidence regarding which allele contributes risk. A meta-analysis
of 5-HTTLPR ﬁndings reported that the S allele was more often
associated with the development of alcohol problems (Feinn et al.,
2005). A separate study found that the S allele placed adolescents
at risk for alcohol use (Brody et al., 2009). Interestingly, although
Brody et al. (2009) found that the S allele represented a risk factor
for alcohol use in youth, the 17 studies analyzed by Feinn et al.
(2005) in their meta-analysis had a mean age range of 39–52 years
of age. The relationship between the serotonin transporter poly-
morphism and AUDs may in fact differ by age, gender, and/or
stage of addiction (Philibert et al., 2008; Merenakk et al., 2011).
Contradictory ﬁndings regarding SLC6A4 may also be explained
by the heterogeneity of alcohol use phenotypes, including vari-
ability in depression and anxiety symptoms (Schuckit and Smith,
2006), comorbidity, and age of onset (Johnson, 2004; Buchmann
et al., 2009). The current study examines the interaction between
depressive symptoms and 5-HTTLPR as a predictor of alcohol use
and related problems in a sample of heavy-drinking young adults.
Previous work on the interaction effects of the serotonin trans-
porter polymorphismhas focused on stress and negative life events
as moderators of the development of AUDs. Psychological stress
has been found tomoderate the effects of the 5-HTTLPR polymor-
phism on alcohol use both in non-human primates (Barr et al.,
2004) and in human samples (Caspi et al., 2010). Alcohol use may
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represent a way to cope with depression and/or anxiety symptoms,
suggesting that these symptoms may moderate the relationship
between SLC6A4 and alcohol misuse (Armeli et al., 2008). Family
history of depression and stressful life events have both been linked
to the development of poor coping skills, which have been directly
associated with alcohol dependence (Schuckit and Smith, 2006).
More recently, two copies of the L allele at the SLC6A4 locus were
associated with higher coping motivations to drink (Armeli et al.,
2008). This relationship was strongest among women, underscor-
ing the role of gender in determining SLC6A4 contribution to
alcohol phenotypes. Genetic studies of family history reveal min-
imal shared genetic etiology between depression and alcoholism,
despite high comorbidity. This is consistent with the hypothe-
sis that symptoms of depression and anxiety may affect AUDs
through an indirect path, rather than shared heritability (Swend-
sen and Merikangas, 2000; Kuo et al., 2006; Sihvola et al., 2008).
These ﬁndings suggest that the high co-occurrence of depression
and AUDs is the result of interactive effects, rather than direct
genetic contribution.
Previous work examining the interactive effects of negative life
events and stresswith the serotonin transporter polymorphismhas
proved inconclusive. The S allele has been associated with more
frequent and heavier drinking in college students who have experi-
enced negative life events (Covault et al., 2007). However, the rela-
tionship between psychosocial adversity and hazardous drinking
in 19-year-old men was such that L allele homozygotes reported
more hazardous drinking after adversity than those with either the
S allele or psychosocial adversity alone (Laucht et al., 2009).
Gendermay play a role in explaining the contradictory ﬁndings,
and has recently been found to affect 5HT mRNA transcription
from the SLC6A4 (Philibert et al., 2008). In this study, both the L
allele and male sex were associated with increased 5HT mRNA
transcription, which in turn was associated with AUDs in the
same sample. Gender differences in the incidence of AUDs and
depression and also in transcriptional activity at the SLC6A4 may
account for some of the mixed results regarding which allelic vari-
ation poses a risk for AUDs. The SS genotype has been associated
with heightened risk for depression, a disorder that is more preva-
lent in women (Caspi, 2003; Hasin et al., 2007), while AUDs are
three timesmore common inmen thanwomen.Additionalwork is
needed to fully elucidate the relationship between the 5-HTTLPR
polymorphism, affective symptoms, and alcohol use; including the
relative contribution of age and gender.
To that end, the present study examined the independent and
interactive effects of the serotonin transporter polymorphism and
depressive symptoms as predictors of alcohol use and alcohol-
related problems in a sample of heavy-drinking young adults. It
is hypothesized that the LL genotype of the 5-HTTLPR polymor-
phismwill be associated with higher levels of drinking and alcohol
problems, based on previous ﬁndings that the L allele results in
increased 5HT mRNA transcription and AUDs in a mixed sample
of depression and alcohol use disordered patients (Philibert et al.,
2008). Consistent with recent ﬁndings among youth, this rela-
tionship is predicted to be stronger at higher levels of depressive
symptoms (Laucht et al., 2009).
MATERIALS AND METHODS
PARTICIPANTS AND PROCEDURES
Participants (n= 72) were heavy drinkers who met the fol-
lowing inclusion criteria: (1) age between 18 and 65; and (2)
score of 8 or higher in the alcohol use disorders identiﬁca-
tion test (AUDIT; Allen et al., 1998), indicating a hazardous
drinking pattern. Exclusion criteria were: (1) currently receiv-
ing treatment for alcohol problems, a history of treatment in
the 30-days before enrollment, or currently seeking treatment;
(2) a lifetime diagnosis of schizophrenia, bipolar disorder, or
psychotic disorder; (3) current and regular (deﬁned as once
weekly) use of any psychoactive drug, other than marijuana, as
determined by self-report. Sample characteristics are provided in
Table 1.
Participants were recruited through ﬂyers and online adver-
tisements for a laboratory study of alcohol craving (Ray, 2010).
Data from this report were culled from the baseline assessment,
before any experimental manipulation of alcohol craving took
place. Interested individuals called the laboratory to complete
telephone screening measures for study eligibility, including the
AUDIT. A total of 161 interested individuals were screened over
the telephone for eligibility and72participantswere enrolled in the
study. Eligible participants came to the laboratory and completed
in-person assessments of depressive symptoms, alcohol use, and
alcohol-related problems.All participants provided a saliva sample
for DNA analyses. A breath alcohol concentration (BAC) of 0.000
was required upon each laboratory visit. This study was approved
by theHumanResearchCommittee at theUniversity of California,
Los Angeles. All participants provided written informed consent
after receiving a full explanation of the study.
Table 1 | Demographic characteristics by 5-HTTLPR genotype [M ± (SD)].
SS (n=22) SL (n=22) LL (n=28) SS/SL1 (n=44) vs. LL (n=28)
Age 20.36± (1.95) 21.45± (4.13) 21.48± (3.49) F (1, 70)=1.284, p=0.261
Gender (male n) 13 14 20 χ2(2, 72)=0.865, p =0.649
Ethnicity (n) χ2(2, 68)=35.75, p<0.001*
African American 0 1 0
Caucasian 11 16 24
Asian 9 3 2
Latino 2 2 2
1Genotype was coded as: SS/SL=1, LL=0.
*Signiﬁcant results are starred.
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ASSESSMENTS
The Beck depression inventory revised
The Beck is as 23-itemmeasure of depressive symptoms occurring
in the past 2 weeks. The BeckDepression Inventory is awidely used
measure in psychological research and practice to identify clini-
cal levels of depression symptoms. The Beck depression inventory
revised (BDI-II) has high internal consistency (alpha-coefﬁcients
for clinical samples≥ 0.88), and content validity compared with
DSM-IV criteria for depression and observer ratings. In addition,
the BDI-II is sensitive to symptom changes over time (Richter
et al., 1998).
The Rutgers alcohol problem index
The Rutgers alcohol problem index (RAPI) is a 23-item measure
used to assess alcohol-related problems in the past year. Possible
total scores range from 0 to 69. RAPI items assess the impact of
alcohol on social and health functioning (White and Labouvie,
1989), and has been found to be valid for use with college-aged
participants (Martens et al., 2007).
30-day timeline follow back interview
The timeline follow back (TLFB) interview was used to assess
drinking behavior in the past 30 days. The TLFB is a calendar-
assisted interview that was used to obtain data on drinking
quantity and frequency. The TLFB accurately estimates alcohol
consumption for as long as a 12-month period (Vakili et al., 2008).
For the purpose of this study, four measures of drinking were
derived from the TLFB interview: (a) total number of drinks con-
sumed in the past 30 days;(b) number of drinking days in the past
30 days; (c) number of binge-drinking days in the past 30 days.
A binge-drinking episode is deﬁned as consuming four or more
drinks for a woman and ﬁve or more drinks for a man (Court-
ney and Polich, 2009); and (d) the average number of drinks per
drinking day in the past 30 days.
GENOTYPING
Saliva samples were collected under researcher observation for
DNAanalyses usingOragene saliva collectionkits.Genotypingwas
performed at the UCLA Genotyping and Sequencing (GenoSeq)
Core. Polymerase chain reaction (PCR) primers were labeled
with ﬂuorescent dye (6-FAM, VIC, or NED), and PCR was per-
formed on Applied Biosystems dual block PCR thermal cyclers.
Microsatellite genotypes were run on an AB 3730 capillary DNA
sequencer and analyzed using the AB GeneMapper software ver-
sion 4.0. The 5-HTTLPR polymorphism at the SLC6A4 locus
was assayed on an AB 7900HT Fast Real-Time PCR System and
analyzed using the Sequence Detection Systems (SDS) software
version 2.3. Each run included two positive control samples (indi-
vidual 2 in CEPH family 1347; Coriell Institute). Genotypes were
automatically scored by the allele calling software, and each geno-
typewas veriﬁed by visual inspection. In process validation checks,
theUCLAGenoSeqCore has average call, reproducibility, and con-
cordance rates of 96, 99.7, and 99.8%, respectively. Quality values
were computed for each genotype call in this sample, using a stan-
dard algorithm that combines various quality metrics. Genotype
calls with a quality score of less than 95% were set to fail. The
primer sequences resulted in alleles that were 484 bp (S allele) or
528 bp (L allele). Consistent with the existing literature, analyses
compared L allele homozygotes to S allele carriers (LL vs. SL/SS).
DATA ANALYSIS
Prior to data analysis, study variables were screened for missing
data, outliers, and distribution abnormalities. Analyses of variance
(ANOVAs) were conducted using the general linear model (Proc
GLM) in SAS statistical package. The primary dependent mea-
sures in this study were: alcohol-related problems (RAPI score),
total number of drinks in the past 30 days, frequency of drinking
in the past 30 days, number of days of binge drinking in the past
30 days, and the average number of drinks per drinking day in the
past 30 days (all derived from the TLFB interview).
Model parameters consisted of the main effects of depressive
symptoms (BDI-II score), 5-HTTLPR genotype, and depressive
symptoms× genotype interaction as predictors of alcohol use and
alcohol problems in this sample. In order to maximize statistical
power, depressive symptoms were treated as a continuous vari-
able in all analyses. Depressive symptom scores were dichotomized
into “high” and “low,” using a median split at a score of 8. This
dichotomy was used solely for graphically representing the results.
In order to quantify effect sizes, partial η2s were computed as rec-
ommended for ANOVA-based models. Partial η2s are deﬁned as
the proportion of variance associated with or accounted for by
each of the main effects or interactions in the ANOVA model.
A dichotomous variable was used for the 5-HTTLPR genotype
(LL= 0, SL and SS= 1). Descriptive statistics and exploratory
analyses were conducted using a three-level genotype variable
(SS= 0, SL= 1, and LL= 2).
RESULTS
GENOTYPE COMPARISONS
Allele frequency did not differ by sex [χ2(2, 68)= 0.68, p> 0.05],
but varied signiﬁcantly by ethnicity. The SS genotype was more
common among African American, Asian, and Latino partici-
pants compared with Caucasian participants [χ2(2, 68)= 35.75,
p< 0.001; see Table 1]. Follow-up analyses were conducted
restricting the sample to Caucasian individuals in order to ensure
that the ﬁndings were not confounded by population stratiﬁca-
tion. Scores on measures of depressive symptoms, alcohol use,
and alcohol problems across genotype are presented in Table 2
and reveal that L allele homozygotes scored signiﬁcantly higher
on alcohol problems, and total reported a higher total number of
drinks (p< 0.05) than S allele carriers. Follow-up analyses adding
age to themodels found no signiﬁcantmain effect of age and there
were no signiﬁcant genotype× age interactions on alcohol use or
alcohol problems.
DEPRESSIVE SYMPTOMS AS MODERATORS OF THE RELATIONSHIP
BETWEEN 5-HTTLPR GENOTYPE AND DRINKING OUTCOMES
As shown in Table 3, results revealed a main effect of depressive
symptomson alcohol-related problems in the past year (p< 0.001)
and on the total number of drinks consumed in a 30-day period
(p< 0.01), such that alcohol-related problems and consumption
increased as depressive symptoms increased. Nomain effects were
found for genotype in predicting drinking frequency of drink-
ing or total number of drinks in the past 30 days. There was a
signiﬁcant genotype× depressive symptom interaction on total
number of drinks, such that at higher levels of depressive symp-
toms, participants who were homozygous for the L allele reported
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signiﬁcantly higher total number of drinks (mean drinks for indi-
viduals above the median BDI-II score= 94.99) compared to S
allele carriers (mean drinks for individuals above themedian BDI-
II score= 48.03; see Figure 1). The interaction between BDI-II
and 5-HTTLPR genotype in predicting alcohol problems (RAPI
Table 2 | Alcohol use, problems, and depressive symptoms by
5-HTTLPR genotype1 [M ± (SD)].
SS/SL (n=44) LL (n=28) SS/LL vs. LL
RAPI total score
(possible range:
0–69)
17.2 (12.96) 28.22 (17.73) t (70)=−3.04;
p=0.010*
BDI-II total score
(possible range:
0–63)
7.25 (7.03) 8.82 (7.69) t (70)=−0.892;
p=0.376
Drinks per
drinking day in
the past 30 days
5.75 (2.57) 7.12 (3.64) t (70)=1.386;
p=0.173
Drinking days in
the past 30 days
9.20 (5.55) 11.67 (5.64) t (70)=1.90;
p=0.062a
Binge-drinking
days in the past
30 days
5.76 (4.54) 8.26 (5.70) t (70)=1.954;
p=0.055a
Total drinks in the
past 30 days
55.86 (43.88) 90.78 (72.05) t (70)=2.23;
p=0.031*
1Genotype was coded as: SS/SL=1, LL=0.
*Signiﬁcant results are starred.
aTrend-level ﬁnding.
Analyses were repeated with ethnicity as a covariate. Genotype remained a sig-
niﬁcant predictor of RAPI score (p=0.017).The addition of ethnicity to the model
reduced the signiﬁcance of genotype as a predictor of total drinks to p=0.074.
scores) was only marginally signiﬁcant (p = 0.071). Mean RAPI
score for L allele homozygotes above the median BDI-II score was
31.57, and 22.94 for S allele carriers. 5-HTTLPR genotype, BDI-
II score, and their interaction were not signiﬁcant predictors of
binge-drinking frequency, the number of drinking days in the past
30 days or the average number of drinks per drinking day; see
Table 3.
FOLLOW-UP ANALYSES OF GENETIC EFFECTS
Analyses of three levels of genotype
The effects of the 5-HTTLPR genotype were examined as a three-
level variable: SS, SL, and LL. ANOVAs, using Proc GLM, revealed
that the interaction of 5-HTTLPR genotype and depressive symp-
toms produced a marginally signiﬁcant increase in total drinks
consumed for each additional L allele. In short, analyses of the 5-
HTTLPR as a three-level variable supported the ﬁndings achieved
with the SS/SL and LL categories and suggest that L allele homozy-
gotes aremost distinct from S allele carriers. Consistent with other
reports, SS and SL individuals were combined into a single group
in order to enhance statistical power.
Analyses of gender and ethnicity effects
In order to account for the possibility that population strati-
ﬁcation confounds the results reported above, we repeated the
analyses described above using only self-identiﬁedCaucasian indi-
viduals (n = 51) and by controlling for ethnicity and gender in
the full sample. Controlling for ethnicity and gender did not
change the results of the main analyses, and revealed a main effect
of ethnicity on the total number of drinks consumed in a 30-
day period (p= 0.002), such that Caucasians had more drinks
than any other group (M = 83.96, SD= 62.13) followed by Asians
(M = 37.61, SD= 17.90) and Latinos (M = 16.83, SD= 16.50).
Only one participant was African American. See Table 4 for full
results. Repeating the analyses only in Caucasians signiﬁcantly
Table 3 | Main analyses of the effect of depressive symptoms, 5-HTTLPR genotype1, and their interaction on alcohol use and alcohol problems.
Dependent variable Model β SE t p η2
Total drinks in past 30 days 5-HTTLPR genotype1 6.988 19.506 0.36 0.721 0.002
BDI-II 3.805 1.344 2.830 0.006* 0.105
Genotype*BDI-II −4.751 1.779 −2.670 0.009* 0.095
Drinking days in past 30 days 5-HTTLPR genotype −0.124 2.572 −0.050 0.962 0.000
BDI-II 0.261 0.177 1.470 0.146 0.031
Genotype*BDI-II −0.377 0.235 −1.610 0.112 0.037
Drinks per drinking day in past 30 days 5-HTTLPR genotype 0.147 1.086 0.135 0.893 0.002
BDI-II 0.088 0.074 1.182 0.241 0.054
Genotype*BDI-II −0.147 0.098 −1.505 0.137 0.028
Binge-drinking days in past 30 days 5-HTTLPR genotype −0.414 1.822 −0.227 0.821 0.001
BDI-II 0.155 0.126 1.231 0.223 0.083
Genotype*BDI-II −0.236 0.166 −1.422 0.160 0.051
Rutgers alcohol problem index score (possible range: 0–69) 5-HTTLPR genotype −1.641 5.002 −0.330 0.744 0.002
BDI-II 1.290 0.345 3.740 <0.001* 0.171
Genotype*BDI-II −0.837 0.456 −1.840 0.071a 0.047
1Genotype was coded as: SS/SL=1, LL=0.
*Signiﬁcant results are starred.
aTrend-level ﬁnding.
Frontiers in Psychiatry | Addictive Disorders August 2011 | Volume 2 | Article 49 | 4
Tartter and Ray 5-HTTLPR, depression, and alcohol use
decreased statistical power to detect genetic effects. We therefore
compared the results of the full sample with the Caucasian sample
using partial η2s. Effect size estimates are ideal for comparisons
with low power, as they are not biased by sample size. Results
of analyses among Caucasian individuals revealed that the effect
size estimates for the BDI-II× 5-HTTLPR were reduced slightly.
The BDI-II× 5-HTTLPR genotype interaction on total number
of drinks had an estimated partial η2 = 0.095 in the full sample
(p = 0.009), as compared to partial η2 = 0.073 (p = 0.060) in the
Caucasian-only sample. These results suggest that the observed
FIGURE 1 |Total drinks in the past 30days (M±SE) across serotonin
transporter genotype (LL vs. SS/SL) and depressive groups (scores on
the BDI, split at the median of 8). Analyses revealed a signiﬁcant
genotype×BDI interaction such that L allele homozygotes reporting high
levels of depressive symptoms reported signiﬁcantly more drinks in the
past 30 days as compared to S allele carriers [F (3, 68)=7.13, p=0.009,
η2 =0.095].
genetic effects are not best explained by ethnicity and provide
further support for the ﬁndings reported above.
DISCUSSION
The current study extends the literature on the serotonin trans-
porter polymorphism and its role in AUDs. Results indicated a
main effect of 5-HTTLPR genotype such that L allele homozygotes
had signiﬁcantly more alcohol problems measured by the RAPI,
and more drinks consumed over a 30-day period than S allele car-
riers. A main effect of depressive symptoms was found, wherein
individuals reporting higher levels of depressive symptoms had
more alcohol use and alcohol-related problems than those with
fewer depressive symptoms. A signiﬁcant 5-HTTLPR×BDI-II
interaction was found; higher scores on the BDI-II were asso-
ciated with more drinks consumed and more drinking days in
the past 30 days among L allele homozygotes. Additionally, the
interaction of 5-HTTLPR genotype and BDI-II scores approached
signiﬁcance in predicting more alcohol-related problems in the
past year. Follow-up analyses using all three levels of genotype (SS,
SL, and LL) revealed that each additional L allele was associated
with an increase in drinking problems for participants reporting
higher levels of depressive symptoms. These results indicate that
the combination of LL genotype and depressive symptomatology
is associated with alcohol use and alcohol-related problems. These
ﬁndings support previous work examining serotonin transporter
polymorphism in amixed clinical sample of depression andAUDs,
as well as previous studies examining gene× environment interac-
tionswith the 5-HTTLPR (Olsson et al., 2005; Philibert et al., 2008;
Laucht et al., 2009). These results stand in contrast with work on
the direct genetic contribution of the serotonin transporter poly-
morphism toAUDs, as we found nomain effect of genotype in the
present study (Feinn et al., 2005; McHugh et al., 2010).
Table 4 | Comparison of ANOVA models controlling for ethnicity and gender with main analyses.
Dependent variable Model 1 β SE t p η2
No of drinks (total) in past 30 days 5-HTTLPR genotype1 6.988 19.506 0.360 0.721 0.002
BDI-II 3.805 1.344 2.830 0.006* 0.105
Genotype*BDI-II −4.751 1.779 −2.670 0.009* 0.095
Model 2
Ethnicity −18.430 5.827 −3.163 0.002* 0.058
5-HTTLPR genotype 10.179 18.358 0.554 0.581 0.002
BDI-II 3.375 1.270 2.656 0.010* 0.260
Genotype*BDI-II −4.055 1.686 −2.405 0.019* 0.085
Rutgers alcohol problem index score (possible range: 0–69) Model 1
5-HTTLPR genotype −1.641 5.002 −0.330 0.744 0.002
BDI-II 1.290 0.345 3.740 <0.001* 0.171
Genotype*BDI-II −0.837 0.456 −1.840 0.071a 0.047
Model 2
Ethnicity −0.599 1.600 −0.374 0.709 0.003
5-HTTLPR genotype −1.538 5.042 −0.305 0.761 0.012
BDI-II 1.276 0.349 3.658 0.001* 0.332
Genotype*BDI-II −0.815 0.436 −1.760 0.083a 0.055
1Genotype was coded as: SS/SL=1, LL=0.
*Signiﬁcant results are starred.
aTrend-level result.
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A recent meta-analysis of serotonin transporter polymorphism
and AUDs found a main effect of S allele across studies in predict-
ing AUDs, but suggested that comorbid alcohol and depression
results in a more complicated picture regarding the effects of the
5-HTTLPR polymorphism (McHugh et al., 2010). The current
study offers support for the L allele as a risk for alcohol use prob-
lems when depressive symptoms are present. Given that this is a
small sample and that few studies have examined the interaction of
5-HTTLPR and mood symptomatology as a predictor of alcohol
problems, these results are preliminary.
Previous work examining interactions between stress and neg-
ative life events with the serotonin transporter polymorphism
has been mixed, but evidence for the L allele as risk factor has
come from both psychosocial (e.g., Olsson et al., 2005; Laucht
et al., 2009) and biological studies (e.g., Philbert) of the serotonin
transporter polymorphism. Olsson et al. (2005) reported a G× E
interaction between 5-HTTLPR genotype and risky attachment
style in predicting both anxiety symptoms and binge drinking.
In risky settings, each additional copy of the S allele lowered the
odds of anxiety (about 30% per allele), and binge drinking (about
35% per allele; Olsson et al., 2005). Laucht et al. (2009) found that
high early life adversity and current stressful events interactedwith
the 5-HTTLPR genotype to predict the number of binge-drinking
days in an adolescent sample. Independent risks for developing an
AUD have also been associated with the L allele, including mech-
anisms of alcohol craving and low level of response to alcohol
(Hinckers et al., 2006; Bleich et al., 2007). The L allele has also
been associated with higher rates of AUD and drinking, and a
lower age of onset of AUDs (Hu et al., 2005; Kweon et al., 2005).
The current ﬁndings stand in contrast to studies ﬁnding a
direct relationship between the S allele of the serotonin trans-
porter polymorphism and AUDs. Covault et al. (2007) found
that S allele homozygotes with multiple negative life events in
the prior year reported more frequent drinking and heavy drink-
ing, stronger intentions to drink, and greater non-prescribed drug
use. Among homozygotes for the L allele, drinking and drug use
were unaffected by past-year negative life events. More recently,
Brody et al. (2009) found that presence of one or two copies of
the S allele was associated with increases in substance use over
time. However, this association was greatly attenuated by support-
ive parenting. Johnson (2000) hypothesized that LL genotype is
more common among early onset AUDs and that the LL genotype
results in reduced levels of intra-synaptic 5-HT. The present results
align with and extend previous work implicating the L allele as a
risk for alcohol-related problems in young adults with depression
symptomatology (Olsson et al., 2005; Laucht et al., 2009).
While studies examining the relationship between the L allele
and alcohol use problems have been conducted in primarily male
samples (Laucht et al., 2009), the present sample is fairly well
balanced on gender across genotype categories. Furthermore, the
relationship between the LL genotype and problematic alcohol use
in the presence of mood symptoms is corroborated by Olsson et
al.’s (2005) large, gender-balanced study of adolescent drinking
and the 5-HTTLPR. This study found that within risky environ-
ments, each additional S allele lowered the risk of anxiety and
drinking problems. Together, these results help elucidate the rel-
ative contribution of gender and age factors on the effects of this
polymorphism regarding alcohol outcomes.
Strengths of the current study include the careful phenotyping
and a sample of young hazardous drinkers. Limitations include the
cross-sectional design and the relatively small sample (n= 72).
While the sample of young heavy drinkers (AUDIT≥ 8) can be
seen as an asset of the study, it also limits the generalizability
of the ﬁndings to heavy-drinking young adults. Additional study
limitations include the temporal coverage of the assessments, as
the BDI-II covered a 2-week period while the TLFB comprised
a 30-day period. Moreover, the relatively low levels of depressive
symptoms in this sample may also limit its generalizability to clin-
ical levels of depression and suggest that further studies in clinical
samples are warranted.
On balance, the present ﬁndings provide evidence for a genetic
contribution of the serotonin transporter polymorphism to alco-
hol use and alcohol problems among individuals reporting higher
levels of depressive symptoms. These results suggest that the LL
genotype may confer risk for alcohol problems in the context
of co-occurring psychiatric symptoms, which is consistent with,
and extends, several recent studies reporting a signiﬁcant asso-
ciation between the LL genotype and alcohol problems in the
presence of environmental stressors (Laucht et al., 2009) and
comorbid internalizing psychopathology (Olsson et al., 2005).
Reﬁning the environmental and psychological moderators of the
association between genes and clinical outcomes is critical to rec-
onciling mixed ﬁndings in psychiatric genetics, including studies
of alcoholism vulnerability.
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